# Gene Therapy in Treating Women With Metastatic Breast Cancer

> **NCT00849459** · PHASE1 · COMPLETED · sponsor: **Max Sung** · enrollment: 3 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **BIOLOGICAL:** adenovirus-mediated human interleukin-12

## Key facts

- **NCT ID:** NCT00849459
- **Lead sponsor:** Max Sung
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2017-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00849459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00849459, "Gene Therapy in Treating Women With Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00849459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*